Your session is about to expire
← Back to Search
Smart Discharges for Improving Child Health Post-Discharge
N/A
Recruiting
Led By Matthew O Wiens, PharmD, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from discharge until 6 months post-discharge
Awards & highlights
Study Summary
This trial seeks to reduce childhood mortality in Uganda by predicting risk of recurrent illness and providing post-discharge support.
Who is the study for?
This trial is for children under five who were hospitalized with a suspected or proven infection in Uganda. Parents must consent to participate. Children directly admitted after birth, previously enrolled, outside the hospital area, with language barriers, or whose parents refuse cannot join.Check my eligibility
What is being tested?
The study tests 'Smart Discharges,' which involves predicting a child's risk of illness after leaving the hospital and providing extra care post-discharge to reduce mortality and improve health-seeking behavior among at-risk children.See study design
What are the potential side effects?
Since this intervention focuses on discharge planning and follow-up rather than medication or medical procedures, traditional side effects are not applicable. However, there may be impacts on family routines or stress levels due to increased monitoring.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from discharge until 6 months post-discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from discharge until 6 months post-discharge
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Post-discharge mortality
Secondary outcome measures
Post-discharge health seeking
Post-discharge re-admission
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Phase 2: Interventional, children 0-59 months of ageExperimental Treatment1 Intervention
Phase 2: Intervention
Group II: Phase 1: Observational, children 0-59 months of ageActive Control1 Intervention
Phase 1: Observational only
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,422 Previous Clinical Trials
2,456,560 Total Patients Enrolled
12 Trials studying Sepsis
28,837 Patients Enrolled for Sepsis
WalimuOTHER
4 Previous Clinical Trials
80,702 Total Patients Enrolled
1 Trials studying Sepsis
60 Patients Enrolled for Sepsis
Mbarara University of Science and TechnologyOTHER
78 Previous Clinical Trials
64,341 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am admitted due to a confirmed or suspected infection.I do not wish to participate in the trial.My child is under five years old.
Research Study Groups:
This trial has the following groups:- Group 1: Phase 2: Interventional, children 0-59 months of age
- Group 2: Phase 1: Observational, children 0-59 months of age
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger